Nitric oxide, cGMP and cAMP modulate nitrobenzylthioinosine-sensitive adenosine transport in human umbilical artery smooth muscle cells from subjectswith gestational diabetes

Citation
C. Aguayo et L. Sobrevia, Nitric oxide, cGMP and cAMP modulate nitrobenzylthioinosine-sensitive adenosine transport in human umbilical artery smooth muscle cells from subjectswith gestational diabetes, EXP PHYSIOL, 85(4), 2000, pp. 399-409
Citations number
46
Categorie Soggetti
Physiology
Journal title
EXPERIMENTAL PHYSIOLOGY
ISSN journal
09580670 → ACNP
Volume
85
Issue
4
Year of publication
2000
Pages
399 - 409
Database
ISI
SICI code
0958-0670(200007)85:4<399:NOCACM>2.0.ZU;2-5
Abstract
Adenosine transport was characterized in human umbilical artery smooth musc le cells isolated from nondiabetic and diabetic pregnant subjects. Transpor t of adenosine was mediated by a Na+-independent transport system inhibited by nanomolar concentrations of nitrobenzylthioinosine (NBMPR) in both cell types. Diabetes increased adenosine transport, an effect that was associat ed with a higher maximal velocity (V-max) for NBMPR-sensitive (es) saturabl e nucleoside transport (18 +/- 2 vs. 61 +/- 3 pmol (mu g protein)(-1) min(- 1), P < 0.05) and the maximal number of binding sites (B-max) for specific [H-3]NBMPR binding (74 +/- 4 vs. 156 +/- 10 pmol (mu g protein)(-1), P < 0. 05), with no significant changes in the Michaelis-Menten (K-m) and dissocia tion (K-d) constants, respectively. Adenosine transport was unaltered by in hibition of nitric oxide (NO) synthase (with 100 mu M N-G-nitro-L-arginine methyl ester, L-NAME) or protein synthesis (with 1 mu M cycloheximide), but was increased by inhibition of adenylyl cyclase activity (with 100 mu M, S Q-22536) in nondiabetic cells. Diabetes-induced adenosine transport was blo cked by L-NAME and associated with an increase in L-[H-3]citrulline formati on from L-[H-3]arginine and intracellular cGMP, but with a decrease in intr acellular cAMP compared with non-diabetic cells. Expression of inducible NO synthase (iNOS) was unaltered by diabetes. Dibutyryl cGMP (dbcGMP) increas ed, but dibutyryl cAMP (dbcAMP) decreased, adenosine transport in non-diabe tic cells. dbcGMP or the NO donor S-nitrosoacetylpenicillamine (SNAP, 100 m u M) did not alter the diabetes-elevated adenosine transport. However, acti vation of adenylyl cyclase with forskolin (1 mu M), directly or after incub ation of cells with dbcAMP, inhibited adenosine transport in both cell type s. Our findings provide the first evidence that adenosine transport in huma n umbilical artery smooth muscle cells is mediated by the NBMPR-sensitive t ransport system es, and that its activity is upregulated by gestational dia betes.